Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Amir Hossein Mohseni

Phase 1 Safety and Immunogenicity Trial of Recombinant Lactococcus Lactis Expressing Human Papillomavirus Type 16 E6 Oncoprotein Vaccine in Healthy Females

Molecular Therapy - Methods and Clinical Development

English

Related publications

Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-Controlled, First-In-Human Phase 1 Trial

English

First-In-Human Phase 1 Trial of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 5 HVR48 (rAd5HVR48) HIV-1 Vaccine

English

Human Papillomavirus Type 16 E7 Oncoprotein mediatesCCNA1promoter Methylation

English

Mechanisms of 2,4-Dinitrochlorobenzene-Induced Acute Inflammation in Human Papillomavirus Type 16 E7 Oncoprotein Expressing Skin

English

Human Papillomavirus (HPV) 16/18 E6 Oncoprotein Expression in Infections With Single and Multiple Genotypes

Cancer Prevention Research

English

Evaluation of Safety and Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine in Healthy Females Between 9 and 26 Years of Age in Sub-Saharan Africa

Human Vaccines and Immunotherapeutics

English

NFX1-123 and Poly(A) Binding Proteins Synergistically Augment Activation of Telomerase in Human Papillomavirus Type 16 E6-Expressing Cells

English

Safety and Immunogenicity of a mRNA-based Chikungunya Vaccine in a Phase 1 Dose-Ranging Trial

International Journal of Infectious Diseases

English

Compromised Spindle Assembly Checkpoint Due to Altered Expression of Ubch10 and Cdc20 in Human Papillomavirus Type 16 E6- And E7-Expressing Keratinocytes

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Amir Hossein Mohseni

Phase 1 Safety and Immunogenicity Trial of Recombinant Lactococcus Lactis Expressing Human Papillomavirus Type 16 E6 Oncoprotein Vaccine in Healthy Females

Related publications

Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-Controlled, First-In-Human Phase 1 Trial

First-In-Human Phase 1 Trial of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 5 HVR48 (rAd5HVR48) HIV-1 Vaccine

Human Papillomavirus Type 16 E7 Oncoprotein mediatesCCNA1promoter Methylation

Mechanisms of 2,4-Dinitrochlorobenzene-Induced Acute Inflammation in Human Papillomavirus Type 16 E7 Oncoprotein Expressing Skin

Human Papillomavirus (HPV) 16/18 E6 Oncoprotein Expression in Infections With Single and Multiple Genotypes

Evaluation of Safety and Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine in Healthy Females Between 9 and 26 Years of Age in Sub-Saharan Africa

NFX1-123 and Poly(A) Binding Proteins Synergistically Augment Activation of Telomerase in Human Papillomavirus Type 16 E6-Expressing Cells

Safety and Immunogenicity of a mRNA-based Chikungunya Vaccine in a Phase 1 Dose-Ranging Trial

Compromised Spindle Assembly Checkpoint Due to Altered Expression of Ubch10 and Cdc20 in Human Papillomavirus Type 16 E6- And E7-Expressing Keratinocytes